TIFFANY JONES: Open Payments
NPI 1285942151 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,954 in 110 payments from 15 companies in 2025. Trend: 2023 $2,133 · 2024 $2,102 · 2025 $1,954
Food & beverage: $1,955
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $477 |
| ABBVIE INC. | 26 | $374 |
| PFIZER INC. | 16 | $264 |
| AstraZeneca Pharmaceuticals LP | 11 | $195 |
| Amgen Inc. | 10 | $159 |
| Lilly USA, LLC | 9 | $151 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
Products named: Ozempic, NURTEC ODT, FARXIGA, UBRELVY, Wegovy, VRAYLAR, MOUNJARO, JARDIANCE.
Industry payments across OH — which companies pay providers there.
